Episeras is a Bluetooth-enabled earpiece with a custom-designed, 3D-printed brain activity sensor which monitors for ...
The Episeras (formerly mjn-SERAS) device, developed by German specialty drugmaker Neuraxpharm and Spanish digital health ...
To find out, pharmaphorum chatted with Jack Kreindler (WellFounded) after his onstage session at Frontiers Health 2025.
UK researchers have developed a platform that can test whether commercial AI algorithms developed for NHS applications are ...
The attraction for Alkermes and Lundbeck in Avadel is Lumryz, an extended-release formulation of the well-established ...
The FDA has started a priority review of BeOne Medicines' BCL2 inhibitor sonrotoclax in relapsed or refractory mantle cell ...
YourCoach Health’s Eugene and Marina Borukhovich spoke with pharmaphorum after their Frontiers Health session to get to the ...
A clinical trial of Vaderis Therapeutics' AKT inhibitor engasertib suggests it could be the first effective treatment for hereditary haemorrhagic telangiectasia (HHT), the second most common inherited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback